REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 96 filers reported holding REGULUS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,723,000 | -53.4% | 1,210,121 | -31.6% | 0.00% | 0.0% |
Q3 2016 | $5,838,000 | +20.3% | 1,769,086 | +5.4% | 0.00% | 0.0% |
Q2 2016 | $4,853,000 | -50.8% | 1,679,088 | +18.0% | 0.00% | -50.0% |
Q1 2016 | $9,863,000 | -17.6% | 1,423,233 | +3.7% | 0.00% | -33.3% |
Q4 2015 | $11,970,000 | +23.6% | 1,372,711 | -7.3% | 0.00% | 0.0% |
Q3 2015 | $9,687,000 | -37.2% | 1,481,195 | +5.2% | 0.00% | -25.0% |
Q2 2015 | $15,435,000 | -14.0% | 1,408,287 | +32.9% | 0.00% | 0.0% |
Q1 2015 | $17,951,000 | +12.1% | 1,059,704 | +6.2% | 0.00% | 0.0% |
Q4 2014 | $16,013,000 | +174.9% | 998,306 | +17.0% | 0.00% | +100.0% |
Q3 2014 | $5,826,000 | -14.7% | 852,959 | +0.4% | 0.00% | 0.0% |
Q2 2014 | $6,828,000 | -7.3% | 849,286 | +4.1% | 0.00% | 0.0% |
Q1 2014 | $7,362,000 | +31.5% | 816,211 | +7.7% | 0.00% | 0.0% |
Q4 2013 | $5,598,000 | +104.7% | 757,577 | +161.2% | 0.00% | +100.0% |
Q3 2013 | $2,735,000 | +24.3% | 290,067 | +29.3% | 0.00% | 0.0% |
Q2 2013 | $2,201,000 | – | 224,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 327,350 | $943,000 | 0.99% |
DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |